Highlights

Feb. 26 Novavax raises revenue forecast on boost from vaccine deals, shares soar RE
Feb. 26 Novavax outlook 2026 adjusted total revenue $230 mln - $270 mln RE
Feb. 26 Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals RE
Feb. 26 Top Midday Gainers MT
Feb. 26 Novavax, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
Feb. 26 Novavax Shares Jump After Swinging to Profit in Q4 MT
Feb. 26 Novavax raises revenue forecast on boost from vaccine deals, shares soar RE
Feb. 26 Earnings Flash (NVAX) Novavax Posts Q4 Total Revenue $147.1M, vs. FactSet Est of $89.8M MT
Feb. 26 Earnings Flash (NVAX) Novavax Posts Q4 EPS $0.11, vs. FactSet Est of $0.48 Loss MT
Jan. 20 Novavax, Inc. Enters into A License and Option Agreement with Pfizer Inc CI
Jan. 20 Novavax Enters Non-Exclusive Licensing Deal With Pfizer MT
Nov. 12 Shah Capital pushes for Novavax sale RE
Nov. 12 Shah Capital pushes for Novavax sale, warns of proxy fight RE
Nov. 12 Shah Capital Urges Novavax Board to Address Operational Inefficiencies and Consider Strategic Merger to Maximize Vaccine Potential CI
Nov. 06 Novavax delays profitability target with eyes on Sanofi-led launches RE
Nov. 06 Novavax, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
Nov. 06 Novavax Stock Edges Higher After 2025 Adjusted Revenue Forecast Raised MT
Nov. 06 Earnings Flash (NVAX) Novavax, Inc. Reports Q3 Revenue $70.4M, vs. FactSet Est of $42.1M MT
Nov. 06 Earnings Flash (NVAX) Novavax Posts Q3 Net Loss $1.25 a Share, vs. FactSet Est of $1.20 Loss MT
Nov. 06 Novavax beats quarterly revenue estimates on milestone payment RE
Nov. 06 Novavax defers profitability target by a year on weak COVID vaccine sales RE
Nov. 04 Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid CI
Nov. 04 Novavax Completes Nuvaxovid US Marketing Authorization Transfer to Sanofi MT
Nov. 04 Novavax - FDA approves transfer of Nuvaxovid authorization to Sanofi - SEC filing RE
25-10-22 Waiting for Elon Zonebourse
No results for this search
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW